You cant trust a chicken

THE CHICKEN IS FINALLY COMING HOME TO ROOST!.
C.D.C. , or the Centre For Disease Control has finally realised that you CANNOT control disease. A fact known to homeopathy since 1890. An enormously profitable billion dollar industry could go belly up, if it becomes obvious that vaccines DO NOT WORK. .
Also not mentioned, is the relationship of this “new” ´flu virus to the haemorrhagic family of viral contagions. When many chicken were slaughtered in Hong Kong , the contents of the corpses were compared to “bloody porridge” . Which relates to my contention that CELLS COUNICATE. If you set up a situation where that communication breaks down , by stress , drugs or vaccines you have a problem .
If you then have a virus that can destroy the “cell communication system” then you end up with “bloody porridge”. It would be interesting to read the confidential files of the C.D.C. !!.

Early Hepatitis B Vaccines and the “Man-Made” Origin of HIV - AIDS
by Leonard G. Horowitz, D.M.D., M.A., M.P.H.
This article regards a matter of global urgency transcending better known AIDS threats. It describes a universal challenge posed by ever increasing numbers of plagues predicted to depopulate at least half of the world’s current human inhabitants within two generations. This documented science virtually proves, through the process of elimination and a review of the most updated evidence, the origin of HIV/AIDS as an iatrogenic (i.e., man-made) outcome of specific vaccination experiments.
Considered reflection on this AIDS science, along with the sociopolitical correlates and antecedents of this current catastrophe, reveals the likelihood that myriad other immune
dysfunctions, autoimmune diseases, and cancers, including leukemias, lymphomas, sarcomas, and other ailments linked to viral infections, have resulted from previously engineered microbes that have by accident or intent found their way from cancer virus laboratories into humanity’s bloodstream by way of the most trusted public health preventative—vaccinations.

Public health officials preparing to battle what they view as an inevitable influenza pandemic say the world lacks the medical weapons to fight the disease effectively, and will not have them anytime soon.
Public health specialists and manufacturers are working frantically to develop vaccines, drugs, strategies for quarantining and treating the ill, and plans for international cooperation, but these efforts will take years. Meanwhile, the most dangerous strain of influenza to appear in decades -- the H5N1 "bird flu" in Asia -- is showing up in new populations of birds, and occasionally people, almost by the month, global health officials say.

If the virus were to start spreading in the next year, the world would have only a relative handful of doses of an experimental vaccine to defend against a disease that, history shows, could potentially kill millions. If the vaccine proved effective and every flu vaccine factory in the world started making it, the first doses would not be ready for four months. By then, the pathogen would probably be on every continent.
Theoretically, antiviral drugs could slow an outbreak and buy time. The problem is only one licensed drug, oseltamivir, appears to work against bird flu. At the moment, there is not enough stockpiled for widespread use. Nor is there a plan to deploy the small amount that exists in ways that would have the best chance of slowing the disease.
The public, conditioned to believe in the power of modern medicine, has heard little of how poorly prepared the world is to confront a flu pandemic, which is an epidemic that strikes several continents simultaneously and infects a substantial portion of the population.
Since the current wave of avian flu began sweeping through poultry in Southeast Asia more than 18 months ago, international and U.S. health authorities have been warning of the danger and trying to mobilize. Research on vaccines has accelerated and efforts to build up drug supplies are underway. The U.S. Department of Health and Human Services will spend $419 million in pandemic planning this year. The National Institutes of Health's influenza research budget has quintupled in the past five years.
Despite these efforts, the world's lack of readiness to meet the threat is huge, experts say. "The only reason nobody's concerned the emperor has no clothes is that he hasn't shown up yet," Harvey V. Fineberg, president of the National Academy of Sciences' Institute of Medicine, said recently of the world's efforts to prepare for pandemic flu. "When he appears, people will see he's naked." Other scientists are sounding the alarm as well.
The most outspoken is Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. In writing and in speeches, Osterholm reminds his audience that after public calamities, the United States usually convenes blue-ribbon commissions to pass judgment. There will be one after a flu pandemic, he believes.
In hopes of slowing a pandemic's spread, public health specialists have been debating proposals for unprecedented countermeasures. These could include vaccinating only children, who are statistically most likely to spread the contagion; mandatory closing of schools or office buildings; and imposing "snow day" quarantines on infected families -- prohibiting them from leaving their homes.

Other measures would go well beyond the conventional boundaries of public health: restricting international travel, shutting down transit systems or nationalizing supplies of critical medical equipment, such as surgical masks. But Osterholm argues that such measures would fall far short. He predicts that a pandemic would cause widespread shutdowns of factories, transportation and other essential industries. To prepare, he says, authorities should identify and stockpile a list of perhaps 100 crucial products and resources that are essential to keep society functioning until the pandemic recedes and the survivors go back to work.
Since late 2003, 109 people are known to have been infected with the emerging H5N1 virus in Asia. About half -- 55 -- have died.
Ironically, for the current H5N1 strain of avian flu to gain "pandemic potential," it will have to become less deadly. Declining lethality is a key sign that the microbe is adapting to human hosts. That is one reason the 34 percent mortality observed in the most recent outbreak -- a cluster of cases in northern Vietnam -- has scientists worried.
Pandemics are caused by strains of virus that are highly contagious and to which people have no immunity. Such strains are rare. They arise from the chance scrambling and recombination of an animal flu virus and a human one, resulting in a strain whose molecular identity is wholly new.
In the 20th century, pandemics occurred in 1918, 1957 and 1968. Although the 19th-century record is less certain, there appear to have been four flu pandemics -- in 1833, 1836, 1847 and 1889. On a purely statistical basis, the nearly 40 years since the last one suggests the time may be ripe.
The microbe called influenza A/H5N1 appeared in East Asia in 1996 and has flared periodically since. It is highly contagious and lethal in chickens, but it can be carried without symptoms in some ducks -- a combination that helps keep it in circulation.
Birds occasionally infect humans, and scientists recently found evidence that the virus is sometimes passed person to person. That form of transmission is now difficult and rare, but the virus could evolve so that it becomes easy and common.
If H5N1 never becomes easily transmissible in human beings, it will never become a pandemic. If it does become transmissible, the consequences are difficult to imagine. But history provides some clues. The "Spanish flu" in 1918 and 1919 was the biggest and, along with AIDS, the most important infectious disease outbreak of the 20th century. It is on the short list of great disasters in human history.
At least 50 million people, and possibly as many as 100 million, died when the world's population was 1.9 billion people, one-third its current size.

Tests are underway at three U.S. hospitals on an experimental vaccine against H5N1. But it is not the first H5N1 vaccine. When a slightly different strain of the virus surfaced in Hong Kong in 1997, killing thousands of chickens and a half-dozen people, researchers used viruses from birds and people to make experimental vaccines. But neither offered much protection in lab tests, and nobody knows why.
Instead of working on the problem, researchers dropped it. First SARS (severe acute respiratory syndrome), and then a different avian flu strain that arose in Europe (H7N7), took their attention.
"The urgency around this issue kind of dissipated," said John Treanor, a physician at the University of Rochester and one of the leaders of the vaccine project. "I think it's an example of how unpredictable things are. We got distracted." The urgency is back.
As the first, small hedge against disaster, the government last fall ordered 2 million doses of H5N1 vaccine from Sanofi Pasteur, one of the country's three flu vaccine makers, even though nobody yet knows whether it works.
A half-dozen other countries are also working on pandemic vaccines. But making enough to fight an outbreak is a tall order.
About 300 million flu shots are made worldwide each year. The vaccine only protects against three flu strains. If the global production capacity were directed to make only H5N1 vaccine, the output could be 900 million shots.
Unfortunately, virologists are almost certain people will need two doses about a month apart to mount a successful immune response against a wholly new strain such as H5N1. That would cut the theoretical number of recipients worldwide to 450 million. If each shot requires a larger-than-usual amount of vaccine to work, the number will be even smaller.
Can the world produce more flu shots? Not easily.